A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Ricolinostat in Patients with Painful Diabetic Peripheral Neuropathy
Study Population:
Patients with Type 1 or Type 2 diabetes suffering from painful distal symmetric sensorimotor polyneuropathy (painful DPN) present for ≥ 6 months who meet all inclusion and exclusion criteria are eligible to participate.
Is diabetes
causing you pain?
Tingling? Numbness?
If yes, you may have a condition known
as painful diabetic peripheral neuropathy
(painful DPN). Learn about the RiNeuD
clinical research study designed to find
out if a potential new medication can help
people with painful DPN.
Who can join the study?
You may be able to join the RiNeuD study if you
meet the following study requirements*:
• Between 18 and 80 years of age
• Diagnosed with diabetes (type 1 or type 2)
at least 6 months ago
• Have pain, tingling, numbness, or weakness
in the hands, legs, or feet
*Other study requirements will apply.